Details of Drug-Drug Interaction
| Drug General Information (ID: DDI28VFIA4) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Sodium bicarbonate | Drug Info | Tolvaptan | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antidiarrheals | Vasopressin Antagonists | |||||||
| Structure | |||||||||
| Mechanism of Sodium bicarbonate-Tolvaptan Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased risk of hypernatremia Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Sodium bicarbonate | Tolvaptan | |||||||
| Mechanism | Hypernatremia | Hypernatremia | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Hypernatremia | ||||||||
| Factor Description | Hypernatremia is defined as a serum sodium concentration >145 mEq/L (>145 mmol/L). It implies a deficiency in total body water due to less water intake than water loss relative to total body sodium. The main symptom is thirst; other clinical manifestations are mainly neurological (due to osmotic transfer of water from brain cells) and include confusion, neuromuscular excitability, seizures and coma. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | The concomitant use of tolvaptan with hypertonic saline is not recommended. Caution and monitoring are recommended for patients who have received other medications that increase serum sodium levels. | ||||||||
